"10.1371_journal.pone.0004792","plos one","2009-03-11T00:00:00Z","David Aviezer; Einat Brill-Almon; Yoseph Shaaltiel; Sharon Hashmueli; Daniel Bartfeld; Sarah Mizrachi; Yael Liberman; Arnold Freeman; Ari Zimran; Eithan Galun","Protalix Biotherapeutics, Science Park, Carmiel, Israel; Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Hospital, Jerusalem, Israel; Gaucher Clinic, Shaare Zedek Medical Center, Jerusalem, Israel","Conceived and designed the experiments: DA EBA AZ EG. Performed the experiments: SM YL AF EG. Analyzed the data: DA EBA SH AZ EG. Contributed reagents/materials/analysis tools: EBA YS SH DB EG. Wrote the paper: DA SH AZ EG.","David Aviezer, Einat Brill-Almon, Yoseph Shaaltiel, Sharon Hashmueli, and Daniel Bartfeld are all employed by Protalix (http://www.protalix.com) the company which sponsored the study and also hold the license for the product. As such holds shares in the company. As aponsors and funders of the study Protalix employees (listed above) had a role in study design and review of data analysis. Eithan Galun was an adviser to Protalix. Ari Zimran is a paid consultant of Protalix. All other authors declare no competing financial interests.","2009","03","David Aviezer","DA",10,TRUE,4,4,5,4,TRUE,TRUE,FALSE,0,NA,FALSE
